SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-027198
Filing Date
2012-05-09
Accepted
2012-05-09 16:33:19
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v311895_10q.htm 10-Q 276092
2 EXHIBIT 31.1 v311895_ex31-1.htm EX-31.1 9718
3 EXHIBIT 31.2 v311895_ex31-2.htm EX-31.2 9821
4 EXHIBIT 32.1 v311895_ex32-1.htm EX-32.1 4075
5 EXHIBIT 32.2 v311895_ex32-2.htm EX-32.2 4189
  Complete submission text file 0001144204-12-027198.txt   1205749

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT plx-20120331.xml EX-101.INS 81611
7 XBRL TAXONOMY EXTENSION SCHEMA plx-20120331.xsd EX-101.SCH 11185
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE plx-20120331_cal.xml EX-101.CAL 26062
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plx-20120331_def.xml EX-101.DEF 69488
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE plx-20120331_lab.xml EX-101.LAB 104317
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plx-20120331_pre.xml EX-101.PRE 81616
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33357 | Film No.: 12826209
SIC: 2836 Biological Products, (No Diagnostic Substances)